Top Markets
#1 Islamic Coin Islamic Coin +152.25%
#2 Bitway Bitway +40.84%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.17%
#4 Starpower Starpower +29.00%
#5 Pleasing Gold Pleasing Gold +28.64%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.29%
#7 Pons Pons +22.64%
#8 aelf aelf +18.42%
#9 Decred Decred +14.29%
#10 Venom Venom +14.02%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Argenica Therapeutics Ltd Argenica Therapeutics Ltd

Argenica Therapeutics Ltd

AGN
Classifica tra le azioni #30346
Argenica Therapeutics Limited, a biotechnology company, engages in the research... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Prezzo delle azioni
$0.14599395
Capitalizzazione di mercato
$18.75M
Variazione (1 giorno)
0.98%
Variazione (1 anno)
-67.69%
Paese
AU
Scambia Argenica Therapeutics Ltd (AGN)

Categoria

Healthcare
Rapporto P/S per Argenica Therapeutics Ltd (AGN)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Argenica Therapeutics Ltd, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Argenica Therapeutics Ltd da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR